Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Sales | 297,485 | 308,159 | 301,526 | 263,253 | 342,227 |
| Cost of Goods | 190,921 | 193,696 | 193,306 | 163,066 | 211,957 |
| Gross Profit | 106,564 | 114,463 | 108,220 | 100,187 | 130,270 |
| Operating Expenses | 63,038 | 64,497 | 68,633 | 753,059 | 63,054 |
| Operating Income | 44,447 | 50,662 | 39,893 | -652,806 | 68,173 |
| Interest Expense | 5,572 | 5,351 | 5,233 | 5,980 | 5,954 |
| Other Income | 1,565 | 1,974 | 367 | -1,916 | 902 |
| Pre-tax Income | 40,440 | 47,285 | 35,027 | -660,702 | 63,121 |
| Income Tax | 6,900 | 13,630 | 10,158 | 6,130 | 17,628 |
| Net Income Continuous | 33,540 | 33,655 | 24,869 | -666,832 | 45,493 |
| Net Income Discontinuous | 3,451 | N/A | N/A | N/A | N/A |
| Minority Interests | -322 | -499 | -536 | -351 | 5 |
| Net Income | $37,313 | $34,154 | $25,405 | $-663,198 | $45,488 |
| EPS Basic Total Ops | 0.57 | 0.53 | 0.39 | -9.86 | 0.68 |
| EPS Basic Continuous Ops | 0.52 | 0.52 | 0.38 | -9.91 | 0.68 |
| EPS Basic Discontinuous Ops | 0.05 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.57 | 0.52 | 0.38 | -9.77 | 0.64 |
| EPS Diluted Continuous Ops | 0.52 | 0.52 | 0.38 | -9.81 | 0.64 |
| EPS Diluted Discontinuous Ops | 0.05 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $69,285 | $73,562 | $61,863 | $79,153 | $91,147 |